Atlas Trials

A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants

Clinical trial NCT01933880 · COMPLETED

Trial details

NCT number
NCT01933880
Sponsor
Xian-Janssen Pharmaceutical Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder (ADHD)
Start date
2009-12-01
Primary completion
2010-11-01
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.